Synucleozid (NSC 377363) is a potent inhibitor of SNCA mRNA encoding α-synuclein; it selectively targets the iron-responsive element (IRE) site in the 5' UTR of α-synuclein mRNA, reducing the amount of SNCA mRNA loaded onto polysomes and thereby inhibiting α-synuclein protein translation; it has potential for research related to Parkinson's disease.